| Name | Title | Contact Details |
|---|---|---|
Vincent Crowe |
Chief Financial Officer | Profile |
Erica Drohan |
Chief Financial Officer | Profile |
Steven Cutbirth |
Vice President of Marketing and Communications | Profile |
Amy Cummings |
Senior Vice President of Business Development and Client Success | Profile |
Jordan Hadas |
Chief Product Officer | Profile |
Symbiomix (sim-bye-OH-mix) is a late-stage, privately held biopharmaceutical company developing innovative medicines for serious women`s health infections that have been long neglected and are in need of new therapeutic options. Symbiomix was founded in 2012 by a team of experienced industry professionals and entrepreneurs and is backed by three of the world`s leading healthcare venture capital firms, OrbiMed, Fidelity Biosciences and HBM Partners. The Company`s lead product is SYM-1219, a novel drug candidate containing secnidazole, which is a next generation 5-nitroimidazole antibiotic. Symbiomix is based in New Jersey, with additional offices in Maryland and Connecticut.
Allegiance Mobile Health is a Texas-based private provider of medical transportation and 911 emergency services. They offer emergent and non-emergent patient transport, mobile integrated health, special event services and consulting, and continuing edu...
Patient Choice Healthcare Inc is a Minneapolis, MN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
NYU Langone Medical Center is one of the leading providers in Healthcare, Pharmaceuticals, & Biotech. It is based in New York, NY. To find more information about NYU Langone Medical Center, please visit www.nyumc.org
American Association of Neuromuscular is a Rochester, MN-based company in the Healthcare, Pharmaceuticals, & Biotech sector.